Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Iterum Therapeutics PLC (ITRM) had Weighted-Average Shares Outstanding (Basic) of 12.96M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-38.37M |
|
-- |
|
-- |
|
$47.47M |
|
$-47.47M |
|
$9.71M |
|
$-37.76M |
|
$-37.76M |
|
$-38.37M |
|
$-38.37M |
|
$-38.37M |
|
$-38.37M |
|
$-47.47M |
|
$-43.38M |
|
Weighted-Average Shares Outstanding (Basic) |
12.96M |
12.96M |
|
$-2.96 |
|
$-2.96 |
|
Balance Sheet Financials | |
$25.60M |
|
$0.05M |
|
$0.66M |
|
$26.26M |
|
$13.52M |
|
$11.45M |
|
$19.14M |
|
$32.66M |
|
$-6.40M |
|
$-6.40M |
|
$-6.40M |
|
13.50M |
|
Cash Flow Statement Financials | |
$-39.33M |
|
$23.34M |
|
$1.03M |
|
$21.13M |
|
$6.11M |
|
$-15.02M |
|
$0.78M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
2.27 |
|
-1.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
599.27% |
|
599.27% |
|
-146.13% |
|
-759.82% |
|
$-0.47 |
|
$-3.04 |
|
$-3.03 |